InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Welch Daniel G, 董事. Director active across 4 companies, notably Seagen Inc.. Aggregated, 17 disclosures have been published. Activity tracked since 14 May 2021. The latest transaction was filed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Welch Daniel G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
5,740 股0Common StockSEC:0000950170-25-074667:0
5,345 股0Common StockSEC:0000950170-24-075488:0
293,203 股@ US$1.74100.0% 占其流量Class A Common StockSEC:0001415889-24-014769:0
4,750 股@ US$229.0048.1% 占其流量Common StockSEC:0000950170-23-070874:0
1,812 股@ US$135.6310.9% 占其流量Common StockSEC:0001203311-23-000087:0
3,860 股0Common StockSEC:0001209191-23-035686:0
2,044 股0Common StockSEC:0001203311-23-000057:0
1,864 股@ US$135.6311.2% 占其流量Common StockSEC:0001203311-23-000046:0
5,150 股@ US$64.3814.5% 占其流量Common StockSEC:0000899243-23-012178:0
995 股@ US$38.821.7% 占其流量Common StockSEC:0000899243-23-010823:0
2,037 股@ US$38.823.5% 占其流量Common StockSEC:0000899243-23-008886:0
5,758 股@ US$38.8210.1% 占其流量Common StockSEC:0000899243-23-008695:0
123,508 股Ordinary SharesSEC:0001209191-23-008168:0
3,300 股0Common StockSEC:0001209191-22-039568:0
1,503 股0Common StockSEC:0000899243-22-018459:0
2,145 股0Common StockSEC:0001209191-21-043549:0
1,402 股0Common StockSEC:0001203311-21-000030:0
17 条申报中的 17 条
About Welch Daniel G
Director of Seagen Inc., Ultragenyx Pharmaceutical Inc., Nuvation Bio Inc. and Structure Therapeutics Inc., WELCH DANIEL G is associated with 17 filings in total. In the sampled recent filings from 2021-05-18 to 2025-05-19, the sell amount is EUR 999207, the buy amount is EUR 0, and the modal transaction nature is Attribution.
